These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4772528)

  • 1. [Treatment of arthrotic irritations with "R-760" (Flazalone) in double blind experiment with phenylbutazone].
    Münzenberg KJ; Zorn B
    Ther Ggw; 1973 Sep; 112(9):1448-59. PubMed ID: 4772528
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind crossover trial comparing a new antirheumatic agent alclofenac with phenylbutazone in chronic rheumatic disorders.
    Anylward M; Davies DB
    Br J Clin Pract; 1972 Nov; 26(11):517-23. PubMed ID: 4563533
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind comparison between 4-allyloxy-3-chlorophenylacetic acid (alclofenac) and phenylbutazone in osteoarthritis.
    Van Hoek J
    Curr Ther Res Clin Exp; 1970 Sep; 12(9):551-5. PubMed ID: 4989683
    [No Abstract]   [Full Text] [Related]  

  • 4. Double blind trial of naphthypramide (DA-992) in osteoarthritis.
    Camarri E; D'Alonzo D; Zaccherotti L
    Curr Ther Res Clin Exp; 1970 Jan; 12(1):1-9. PubMed ID: 4983479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rofenid in the treatment of coxarthrosis. Double-blind study].
    Famaey JP; Colinet E
    Brux Med; 1975 Jan; 55(1):23-9. PubMed ID: 1090343
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind comparison of niflumic acid with phenylbutazone, oxyphenylbutazone and placebo in the treatment of osteoarthrosis.
    El-Mehairy MM; Shaker A; Bahgat NE; Hamza S; Salam MS
    Rheumatol Rehabil; 1974 Nov; 13(4):198-203. PubMed ID: 4614368
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind trial of a new anti-inflammatory drug in the management of osteo-arthritis of the hip-joint.
    Molony J; Pigott PV; Quill JO
    J Ir Med Assoc; 1971 Nov; 64(424):605-10. PubMed ID: 4940697
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind comparison of phenylbutazone and aspirin in osteoarthritis.
    Scharff EU
    Curr Ther Res Clin Exp; 1974 Dec; 16(12):1264-9. PubMed ID: 4218154
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenylbutazone and aspirin in osteoarthritis: a controlled study.
    Curr Ther Res Clin Exp; 1975 May; 17(5):444-51. PubMed ID: 805028
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis.
    Mizushima Y; Shiokawa Y; Honma M; Kageyama T
    Int J Tissue React; 1983; 5(1):35-9. PubMed ID: 6345427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-inflammatory and analgesic efficiency of a biologic preparation in arthrosis. Comparative controlled study].
    Pipino F; Franchin F
    MMW Munch Med Wochenschr; 1975 Oct; 117(43):1743-4. PubMed ID: 810707
    [No Abstract]   [Full Text] [Related]  

  • 12. Ketoprofen in the management of osteoarthrosis of the hip: comparison with phenylbutazone.
    Bresnihan FP; Grahame R; Burry HC
    Rheumatol Rehabil; 1974 Aug; 13(3):125-31. PubMed ID: 4608933
    [No Abstract]   [Full Text] [Related]  

  • 13. [Meprotixol (N 7020). Studied in rheumatic diseases in a double blind multicenter investigation in general practice].
    Kogstad O; Apall-Olsen P; Fjerdingstad S; Garfelt R; Helgesen RO; Joheim I; Klaastad R; Rosenberg I; Selvåg J; Toreid K; Tonnessen JS
    Tidsskr Nor Laegeforen; 1974 Feb; 94(4):209-12. PubMed ID: 4595468
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative double blind study of pirprofen, indomethacin, and placebo in the treatment of osteoarthritis of the spine].
    Dolanc B; Morscher E
    Nouv Presse Med; 1982 Aug; 11(33):2500-2. PubMed ID: 7133973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical efficacy and tolerance of a new anti-inflammatory agent, carprofen, in osteoarthritis. Comparative double-blind study with naproxen].
    Cozzolino F; Costa L; Marasco E
    Clin Ter; 1983 Sep; 106(6):435-9. PubMed ID: 6357596
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of 804 CB and phenylbutazone. Double blind test of venous and arterial pathology].
    Beurey J; Weber M; Toussain P; Jacob M
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1432-4. PubMed ID: 4480072
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of osteoarthrosis with a new nonsteroidal anti-inflammatory agent, carprofen].
    Pipino F; Busetto M; Franchin F; Punzi L; Todesco S
    Clin Ter; 1984 Mar; 108(5):405-10. PubMed ID: 6232077
    [No Abstract]   [Full Text] [Related]  

  • 18. Piroxicam and naproxen in the treatment of osteoarthritis.
    Hybbinette CH
    Br J Clin Pract; 1981 Jan; 35(1):30-4. PubMed ID: 7020730
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hexahydropyrazine salt of phenylbutazone in O.R.L].
    Laccourreye H
    Ann Otolaryngol Chir Cervicofac; 1970 Jun; 87(6):397-402. PubMed ID: 5424469
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug treatment of rheumatic disorders in general practice. A comparative study of aspirin and an alkali-phenylbutazone preparation.
    Lewis-Faning E; Fowler PD
    Br J Clin Pract; 1971 Mar; 25(3):123-9. PubMed ID: 4929158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.